BCL2L2 anticorps
Aperçu rapide pour BCL2L2 anticorps (ABIN6654583)
Antigène
Voir toutes BCL2L2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Purification
- Purified
-
Pureté
- Protein G affinity chromatography
-
Immunogène
- Full-length recombinant human protein was used as the immunogen for this Bcl2L2 antibody.
-
Isotype
- IgG1
-
-
-
-
Indications d'application
-
The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the Bcl2L2 antibody to be titered up or down for optimal performance.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. Immunohistochemistry (FFPE): 0.5-1 μg/mL for 30 min at RT,Prediluted IHC only format: incubate for 30 min at RT (1) -
Restrictions
- For Research Use only
-
-
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Agent conservateur
- Azide free
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store the Bcl2L2 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
-
-
- BCL2L2 (BCL2-Like 2 (BCL2L2))
-
Autre désignation
- Bcl2L2 / Bcl-W
-
Sujet
- Bcl2L2, also called BCLW, promotes cell survival. Blocks dexamethasone-induced apoptosis. Mediates survival of postmitotic Sertoli cells by suppressing death-promoting activity of BAX.
Antigène
-